Associated Papers
Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling.
Kuusanmäki H et al.
Oncotarget, 2017
29228628 (PubMed )
Supplement: oncotarget-08-97516-s004.xlsx › Sheet1
The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia.
Rajala HL et al.
Haematologica, 2015
Select a paper to view details